LSG Infusion Services
LSG Infusion Services is a premier outpatient infusion center located near Cooperman Barnabas Medical Center in Livingston, New Jersey. Led by Dr. Anthony Botti, a board-certified hematologist-oncologist, the center provides high-quality infusion and injection treatments for various chronic conditions. Committed to excellence, safety, and patient-centered care, LSG Infusion Services collaborates closely with referring physicians, offers detailed treatment reports, and assists with insurance and patient assistance programs. The center treats conditions such as osteoporosis, inflammatory bowel diseases, rheumatoid arthritis, lupus, multiple sclerosis, anemia, and more, ensuring safe, convenient, and comfortable care in a state-of-the-art facility.
Industries
Nr. of Employees
small (1-50)
LSG Infusion Services
Products
Tocilizumab (IL‑6 receptor inhibitor) — IV infusion
IV infusion dosing regimens for treatment of rheumatoid arthritis administered in an outpatient clinic (60-minute infusion every 4 weeks; dosing weight-based).
Vedolizumab — IV infusion for inflammatory bowel disease
Intravenous biologic infusion for treatment of moderately to severely active ulcerative colitis and Crohn's disease following labeled induction and maintenance schedules.
Intravenous iron formulations
Administration of IV iron therapies using multi-dose regimens for treatment of iron-deficiency anemia (examples include ferumoxytol and ferric carboxymaltose dosing patterns described on site).
Subcutaneous osteoporosis biologics (romosozumab, denosumab)
Clinic-administered subcutaneous injections for osteoporosis (examples include monthly or annual dosing schedules for bone-targeted biologics).
Intravenous immunoglobulin (IVIG)
Provision of IVIG infusions with individualized dosing and case-by-case clinical assessment.
Growth factor injections (ESAs and G‑CSF)
Administration of hematopoietic growth factor injections and supportive agents in the clinic setting.
Tocilizumab (IL‑6 receptor inhibitor) — IV infusion
IV infusion dosing regimens for treatment of rheumatoid arthritis administered in an outpatient clinic (60-minute infusion every 4 weeks; dosing weight-based).
Vedolizumab — IV infusion for inflammatory bowel disease
Intravenous biologic infusion for treatment of moderately to severely active ulcerative colitis and Crohn's disease following labeled induction and maintenance schedules.
Intravenous iron formulations
Administration of IV iron therapies using multi-dose regimens for treatment of iron-deficiency anemia (examples include ferumoxytol and ferric carboxymaltose dosing patterns described on site).
Subcutaneous osteoporosis biologics (romosozumab, denosumab)
Clinic-administered subcutaneous injections for osteoporosis (examples include monthly or annual dosing schedules for bone-targeted biologics).
Intravenous immunoglobulin (IVIG)
Provision of IVIG infusions with individualized dosing and case-by-case clinical assessment.
Growth factor injections (ESAs and G‑CSF)
Administration of hematopoietic growth factor injections and supportive agents in the clinic setting.
Services
On-site administration of IV and subcutaneous therapies for chronic and acute conditions in a freestanding infusion clinic.
On-site administration of IV and subcutaneous therapies for chronic and acute conditions in a freestanding infusion clinic.
Expertise Areas
- Outpatient infusion therapy
- Infusion nursing and patient monitoring
- Biologic and monoclonal antibody administration
- Intravenous iron therapy
Key Technologies
- Intravenous infusion administration
- Subcutaneous injection administration
- Intravenous iron infusion protocols
- Monoclonal antibody infusion techniques